133 related articles for article (PubMed ID: 9076859)
1. Significance of monitoring plasma levels of amitriptyline, and its hydroxylated and desmethylated metabolites in prediction of the clinical outcome of depressive state.
Shimoda K; Yasuda S; Morita S; Shibasaki M; Someya T; Bertilsson L; Takahashi S
Psychiatry Clin Neurosci; 1997 Feb; 51(1):35-41. PubMed ID: 9076859
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic blood levels.
Boyer WT
Am J Psychiatry; 1985 Nov; 142(11):1388. PubMed ID: 4061701
[No Abstract] [Full Text] [Related]
3. A method for the determination of amitriptyline and its metabolites nortriptyline, 10-hydroxyamitriptyline, and 10-hydroxynortriptyline in human plasma using stable isotope dilution and gas chromatography-chemical ionization mass spectrometry (GC-CIMS).
Garland WA; Muccino RR; Min BH; Cupano J; Fann WE
Clin Pharmacol Ther; 1979 Jun; 25(6):844-56. PubMed ID: 376209
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of amitriptyline, nortriptyline and four hydroxylated metabolites in serum by capillary gas-liquid chromatography with nitrogen-phosphorus-selective detection.
Ulrich S; Isensee T; Pester U
J Chromatogr B Biomed Appl; 1996 Oct; 685(1):81-9. PubMed ID: 8930756
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of tricyclic antidepressants in clinical practice.
Hollister LE
J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic antidepressant plasma levels: the state of the art and clinical prospects.
Razavi D; Mendlewicz J
Neuropsychobiology; 1982; 8(2):73-85. PubMed ID: 7070646
[TBL] [Abstract][Full Text] [Related]
7. Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients.
Robinson DS; Cooper TB; Howard D; Corcella J; Albright D
J Clin Psychopharmacol; 1985 Apr; 5(2):83-8. PubMed ID: 3988974
[TBL] [Abstract][Full Text] [Related]
8. The role of plasma concentrations in the use of tricyclic antidepressant drugs.
Levine RR
Prog Neuropsychopharmacol; 1979; 3(1-3):211-22. PubMed ID: 401340
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
Lydiard RB
J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites in streptozocin-induced diabetic rats.
Coudoré F; Besson A; Courteix C; Eschalier A; Lavarenne J; Fialip J
Gen Pharmacol; 1996 Jul; 27(5):803-7. PubMed ID: 8842682
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics of nortriptyline and amitriptyline: two case reports.
Franssen EJ; Kunst PW; Bet PM; Strack van Schijndel RJ; van Loenen AC; Wilhelm AJ
Ther Drug Monit; 2003 Apr; 25(2):248-51. PubMed ID: 12657923
[TBL] [Abstract][Full Text] [Related]
12. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
[TBL] [Abstract][Full Text] [Related]
13. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
Sabelli HC; Fawcett J; Javaid JI; Bagri S
Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
[TBL] [Abstract][Full Text] [Related]
14. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
Miljković B; Pokrajac M; Timotijević I; Varagić V
Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
[TBL] [Abstract][Full Text] [Related]
15. [Grapefruit juice as a contraindication? An approach in psychiatry].
Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of amitriptyline by Cunninghamella elegans.
Zhang D; Evans FE; Freeman JP; Duhart B; Cerniglia CE
Drug Metab Dispos; 1995 Dec; 23(12):1417-25. PubMed ID: 8689954
[TBL] [Abstract][Full Text] [Related]
17. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
Perry PJ; Zeilmann C; Arndt S
J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
[TBL] [Abstract][Full Text] [Related]
18. Rates of in vivo methylation of desipramine and nortriptyline.
Kurpius MP; Alexander B
Pharmacotherapy; 2006 Apr; 26(4):505-10. PubMed ID: 16553509
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients: a therapeutic window relationship.
Ulrich S; Northoff G; Wurthmann C; Partscht G; Pester U; Herscu H; Meyer FP
Pharmacopsychiatry; 2001 Jan; 34(1):33-40. PubMed ID: 11229620
[TBL] [Abstract][Full Text] [Related]
20. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
Amsterdam J; Brunswick D; Mendels J
Am J Psychiatry; 1980 Jun; 137(6):653-62. PubMed ID: 6990798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
